Efken, P
10  results:
Search for persons X
?
1

P850 Symptomatic effectiveness of ozanimod in routine clini..:

Schubert, S ; Stein, J ; Efken, P...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1578-i1579 , 2024
 
?
2

P792 Real-world evidence comparison of the effectiveness of..:

Bokemeyer, B ; Plachta-Danielzik, S ; Howaldt, S...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1480-i1481 , 2024
 
?
3

P784 Real-world use and 6-month effectiveness of vedolizuma..:

Plachta-Danielzik, S ; Bokemeyer, B ; Efken, P...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i918-i919 , 2023
 
?
4

P742 Real-world evidence comparison on the effectiveness of..:

Bokemeyer, B ; Plachta-Danielzek, S ; Howaldt, S...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i872-i873 , 2023
 
?
5

P414 Comparative real-world effectiveness and persistence o..:

Bokemeyer, B ; Plachta-Danielzik, S ; Efken, P...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i543-i544 , 2023
 
?
6

P801 Maintenance phase effectiveness and persistence after ..:

Plachta-Danielzik, S ; Bokemeyer, B ; Efken, P...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i933-i934 , 2023
 
?
7

DOP77 Comparative real-world effectiveness and persistence ..:

Di Giuseppe, R ; Plachta-Danielzik, S ; Bokemeyer, B...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i120-i121 , 2022
 
?
8

OP17 Maintenance phase propensity score adjusted effectiven..:

Plachta-Danielzik, S ; di Giuseppe, R ; Bokemeyer, B...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i018-i019 , 2022
 
?
 
1-10